Drug Shortage Report for TEVA-FUROSEMIDE
Report ID | 120914 |
Drug Identification Number | 00337730 |
Brand name | TEVA-FUROSEMIDE |
Common or Proper name | FUROSEMIDE 20MG TAB |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | FUROSEMIDE |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | C03CA |
ATC description | HIGH-CEILING DIURETICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-07-23 |
Estimated end date | 2021-02-28 |
Actual end date | 2021-01-27 |
Shortage status | Resolved |
Updated date | 2021-01-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v15 | 2021-01-28 | French | Compare |
v14 | 2021-01-28 | English | Compare |
v13 | 2021-01-14 | French | Compare |
v12 | 2021-01-14 | English | Compare |
v11 | 2020-10-30 | French | Compare |
v10 | 2020-10-30 | English | Compare |
v9 | 2020-10-08 | French | Compare |
v8 | 2020-10-08 | English | Compare |
v7 | 2020-09-03 | French | Compare |
v6 | 2020-09-03 | English | Compare |
v5 | 2020-08-13 | French | Compare |
v4 | 2020-08-13 | English | Compare |
v3 | 2020-07-24 | English | Compare |
v2 | 2020-07-23 | French | Compare |
v1 | 2020-07-23 | English | Compare |
Showing 1 to 15 of 15